Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market to Grow on the Back of Increasing Prevalence of Chronic Diseases; Market to Grow with a CAGR of 6.7% During 2021-2030

Kenneth Research has released a report titled “Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market: Demand Analysis & Opportunity Outlook 2030” which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, along with the impact of COVID-19 and a detailed discussion on the latest trends and future opportunities that are associated with the growth of the market.

In one of the statistics by the European Commission, there were 1.68 Million deaths in the European Union, in the year 2018, due to the diseases of the circulatory system. Additionally, the World Health Organization (WHO), stated that in the same region, about 60 Million people above the age of 25 years were known to have diabetes.

The statistics portray the growing prevalence of chronic diseases in Europe, which is driving the need amongst the pharmaceutical drug manufacturers to develop advanced pharmaceutical drugs to treat these diseases. Modern medicines require active pharmaceutical ingredients for the production of these drugs, which is expected to drive the growth of the Europe pharmaceutical contract development and manufacturing organization (CDMO) market in the coming years. Additionally, increasing need for research and developments in the field of medical sciences, along with the presence of numerous pharmaceutical drug manufacturers in the region, are some of the factors anticipated to create numerous opportunities for market growth in the coming years.

The Europe pharmaceutical contract development and manufacturing organization (CDMO) market is anticipated to grow with a CAGR of 6.7% during the forecast period, i.e., 2021-2030. The market is estimated to garner a revenue of USD 39920.2 Million by the end of 2030. Moreover, in the year 2020, the market in the nation generated a revenue of USD 21133.3 Million. The market is segmented by end-user into pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes. By the end of 2030, the pharmaceutical & biopharmaceutical companies segment is anticipated to garner the largest revenue of USD 27756.1 Million, up from a revenue of USD 14771.1 Million in the year 2020.

By country, the Europe pharmaceutical contract development and manufacturing organization (CDMO) market is segmented into Germany, United Kingdom, France, Italy, Spain, Russia, and the Rest of Europe, out of which, the market in Italy is anticipated to garner the largest revenue of USD 8942.1 Million by the end of 2030, up from a revenue of USD 4860.7 Million in the year 2020.

However, the stringent government regulations, and the loss of intellectual property are some of the major factors predicted to hinder the market growth in the coming years.

This report also provides the existing competitive scenario of some of the key players of the Europe pharmaceutical contract development and manufacturing organization (CDMO) market, which includes company profiling of Hangzhou Tigermed Consulting Co., Ltd, ICON plc, IQVIA Inc., LSK Global Pharma Services Co., Ltd., Parexel International Corporation, PPD Inc., Almac Group, Quanticate International Limited, Samsung Biologics, Syneos Health, Wuxi Apptec Co., Ltd., Delpharm Holding, Evonik Industries AG, Siegfried Holding AG, Aenova Group, Baxter International, Inc., Boehringer Ingelheim International GmbH, Catalent, Inc., Famar Group, Jubilant Pharmova Limited, Lonza, CMIC HOLDINGS Co., LTD., Labcorp Drug Development, Thermo Fisher Scientific Inc., Pfizer Inc., Recipharm AB, Vetter Pharma-Fertigung GmbH & Co. KG, Charles River Laboratories International, Inc., and others.

The profiling enfolds key information of the companies which comprises of business overview, products and services, key financials and recent news and developments. Conclusively, the report titled “Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market: Demand Analysis & Opportunity Outlook 2030”, analyses the overall Europe pharmaceutical contract development and manufacturing organization (CDMO) industry to help new entrants to understand the details of the market. In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the Europe pharmaceutical contract development and manufacturing organization (CDMO) market in the near future.

Request Report Sample@ https://www.kennethresearch.com/sample-request-10352351

Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: sales@kennethresearch.com

U.S. Phone: +1 313 462 0609